Use of the D test method to detect inducible clindamycin resistance in coagulase negative staphylococci (CoNS)

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 186-188

  Perez, Leandro Reus Rodrigues ^a   Caierão, Juliana ^a   Antunes, Ana Lúcia Souza ^a,b   d'Azevedo, Pedro Alves ^a  

^a Foundation of Federal Clinical Medical School of Port Alegre   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Clindamycin; D test; Resistance

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; OXACILLIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; BRAZIL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; HOSPITAL PATIENT; HUMAN; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS;

EID: 34547138899     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000200002     Document Type: Article

References (19)

1. Fluit A.C., F.-J. Schmitz, M. E. Jones, et al. Verhoef for the SENTRY Participants Group. (1999). Antimicrobial resistance among community-acquired pneumoniae isolates in Europe: First results from the SENTRY antimicrobial surveillance program. Int J Infect Dis 1997; 3:153-6.
2. Fluit A.C., M.E. Jones, F.-J. Schmitz, et al. Bacteremia in European hospitals, incidence and antimicrobial susceptibility. Clin Infect Dis 2000;30:454-60.
3. Fluit A.C., M.E. Jones, F.J. Schmitz, et al. Antimicrobial resistance among Urinary Tract Infection (UTI) isolates in Europe: Results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Leeuwenhoek 2000;77:147-52.
4. Jenssen W.D., S. Thakker-Varia, D.T. Dubin, M.P. Weinstein. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother 1987;31:883-8.
5. Arthur M., C. Molinas, C. Mabilat, P. Courvalin. Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob Agents Chemother 1990;34:2024-6.
6. Eady E.A., J.I. Ross, J.L. Tipper, et al. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 1993;31:211-7.
7. Allignet J., N. El Solh. Diversity among the Gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB. Antimicrob Agents Chemother 1995;39:2027-36.
8. Allignet J., S. Aubert, A. Morvan, N.El Sohl. Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics. Antimicrob Agents Chemother 1996;40:2523-8.
9. Allignet J., N. Liassine, N. El Sohl. Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics. Antimicrob Agents Chemother 1998; 42:1794-8.
10. Jensen L.B., N. Frimondt-Moller, F.M. Aarestrup. Presence of erm gene classes in Gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol Lett 1999;170:151-8.
11. Leclercq R., R.B. Giannattasio, H.J. Jin, B. Weisblum. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991;35:1267-72.
12. Weisblum B. Resistance to macrolide-lincosamide-streptogramin antibiotics, p. 682-98. In: V.A. Fischetti (ed.), Gram-positive pathogens. American Society for Microbiology, Washington, D.C., 1999.
13. Eady E.A., J.I. Ross, J.L. Tipper, et al. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 1993;31:211-7.
14. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., Jorgensen J.H. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003;41:4740-4.
15. Sanchez, M. L., K. K. Flint, and R. N. Jones. Occurrence of macrolidelincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem? Diagn Microbiol Infect Dis 1993;16:205-13.
16. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., Jorgensen J.H. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003;41:4740-4.
17. Panagea S., Perry J.D., Gould F.K. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 1999;44:581-2.
18. National Committee for Clinical Laboratory Standards - NCCLS. Performance Standards for Antimicrobial Disk Susceptibility Tests. M100-S14. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.
19. National Nosocomial Infections Surveillance (NNIS) System. (1999). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999;27:520-32.